GO:0051747 cytosine C-5 DNA demethylase activity

Cytosine C-5 DNA demethylase activity (GO:0051747) is a molecular function that catalyses the hydrolytic removal of the methyl group from the 5 position of cytosine in DNA, converting methyl-dCpdG DNA and water into dCpdG DNA and methanol. This activity is central to the dynamic regulation of DNA methylation, a major epigenetic mark that controls gene expression, chromatin structure, and genome stability. Because DNA methylation is reversible, the enzymes that write, read, and erase this mark are of intense interest in cancer biology, developmental biology, and neuroscience. The same protein can display context-dependent catalytic plasticity: the local chromatin microenvironment determines whether the enzyme behaves as a DNA methyltransferase, a DNA demethylase, or a DNA dehydroxymethylase. This means that the net methylation state of a locus is not simply a function of enzyme abundance, but of the chromatin context in which the enzyme operates. Understanding GO:0051747 therefore requires integrating enzymology with chromatin biology. For researchers, GO:0051747 provides a precise functional annotation for genes and proteins that erase cytosine methylation. It enables systematic comparison of demethylase candidates, supports the design of loss-of-function and gain-of-function experiments, and helps interpret epigenomic data in disease models. This article summarises the definition, mechanism, key genes, disease links, and experimental strategies for studying cytosine C-5 DNA demethylase activity.

GO:0051747 cytosine C-5 DNA demethylase activity is defined as the catalysis of the reaction: methyl-dCpdG DNA + H2O = dCpdG DNA + methanol. In plain terms, it is the hydrolytic removal of the methyl group on the 5 position of cytosine in DNA. The reaction regenerates unmodified cytosine and releases methanol as a by-product. The term is a molecular_function in the Gene Ontology and includes synonyms such as DNA demethylase activity, DNA methyltransferase activity acting on cytosine C-5, and hydrolytic DNA demethylase activity. Because the reaction is hydrolytic, it does not require a cofactor such as alpha-ketoglutarate or iron in its simplest formulation, although in cells the local chromatin microenvironment can shift the same enzyme between methylation, demethylation, and dehydroxymethylation modes.

Cytosine C-5 DNA demethylase activity is important because DNA methylation is a reversible epigenetic mark that controls gene expression programmes, and the ability to erase this mark is essential for developmental transitions, cellular reprogramming, and the response to environmental signals. The same catalytic activity can be redirected by the local chromatin microenvironment to perform methylation, demethylation, or dehydroxymethylation, which means that the functional output of a demethylase candidate cannot be predicted from sequence alone. This plasticity has direct implications for cancer, where aberrant promoter hypermethylation can silence tumour suppressor genes, and for regenerative medicine, where efficient demethylation is required for induced pluripotent stem cell generation. Studying GO:0051747 therefore provides a mechanistic handle on epigenetic reprogramming and a route to therapeutic strategies that target DNA methylation dynamics.

The following genes and proteins have been associated with cytosine C-5 DNA demethylase activity or with the context-dependent catalytic switching between DNA methylation and demethylation described for GO:0051747.

The activity of cytosine C-5 DNA demethylase is regulated by the local chromatin microenvironment, which determines whether the enzyme functions as a DNA methyltransferase, a DNA demethylase, or a DNA dehydroxymethylase. This context dependence means that histone modifications, chromatin-associated proteins, and the broader epigenetic state of a locus can switch the catalytic output of the same enzyme. Consequently, regulation is not limited to enzyme abundance or post-translational modification but includes the physical and biochemical environment in which the enzyme encounters its substrate.

Aberrant DNA methylation can silence tumour suppressor genes, and the balance between methylation and demethylation is frequently disrupted in cancer. Because the local chromatin microenvironment determines whether an enzyme acts as a methyltransferase or demethylase, cancer-associated changes in chromatin state can shift this balance and promote hypermethylation of CpG islands. Studying GO:0051747 in cancer models helps clarify whether restoring demethylase activity can reactivate silenced genes.

DNA methylation is essential for genomic imprinting and developmental gene regulation, and errors in demethylation can lead to imprinting disorders. The context-dependent nature of cytosine C-5 DNA demethylase activity means that developmental signals that remodel chromatin can directly influence demethylation outcomes. Experimental models that manipulate chromatin context are therefore valuable for understanding developmental epigenetic disease.

Dynamic DNA methylation is increasingly recognised in neuronal function and degeneration, and demethylase activity contributes to activity-dependent gene expression. Because the same enzyme can switch between methylation and demethylation depending on chromatin context, neuronal chromatin remodelling may alter the net methylation landscape. This provides a rationale for studying GO:0051747 in neurodegeneration models.

Bisulfite sequencing converts unmethylated cytosine to uracil while methylated cytosine remains unchanged, allowing single-base resolution mapping of DNA methylation. This method is the gold standard for measuring the net output of cytosine C-5 DNA demethylase activity across the genome. Locus-specific bisulfite pyrosequencing can be used to validate candidate regions after CRISPR perturbation.

Chromatin immunoprecipitation followed by sequencing (ChIP-seq) can map the binding of demethylase candidates and chromatin modifiers, revealing the local chromatin microenvironment that determines catalytic output. Combining ChIP-seq with bisulfite sequencing helps link enzyme occupancy to changes in cytosine methylation.

In vitro demethylase assays using methylated DNA substrates can directly measure the hydrolytic release of methanol or the appearance of unmodified cytosine. These assays are useful for testing whether a candidate enzyme retains catalytic activity after point mutation or knockout.

Pooled CRISPR screens can identify genes that modify cytosine C-5 DNA demethylase activity or that determine chromatin context permissiveness. Coupling screens with methylation readouts enables unbiased discovery of regulators of demethylation.

Researchers studying cytosine C-5 DNA demethylase activity-related genes often need to determine whether a candidate gene is causally involved in methylation dynamics or whether its association is secondary to chromatin context. EDITGENE provides CRISPR-engineered cell models and screening services that enable precise, reproducible testing of demethylase function in disease-relevant backgrounds.

Cytosine C-5 DNA demethylase activity (GO:0051747) is a hydrolytic molecular function that erases the methyl mark from the 5 position of cytosine, releasing methanol and regenerating unmodified DNA. Its context-dependent nature, where the local chromatin microenvironment dictates whether the same enzyme methylates, demethylates, or dehydroxymethylates DNA, makes it a central node in epigenetic regulation. Understanding this activity is essential for cancer biology, developmental epigenetics, and regenerative medicine. Researchers can now dissect GO:0051747 with CRISPR knockout, point mutation, knock-in, and overexpression models combined with bisulfite sequencing and chromatin profiling. EDITGENE provides these models and bioinformatics services to accelerate mechanistic and translational studies of cytosine C-5 DNA demethylase activity.